Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eszopiclone 6-Month Efficacy and Safety Study in Primary Insomnia
NCT00352144Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Oct 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eszopiclone in Insomnia, sponsored by Sumitomo Pharma America. Started Oct 2003; status: completed.
02
Drugs
eszopiclone
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00352144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352144.